Cardiovascular disease and non-steroidal anti-inflammatory drug prescribing in the midst of evolving guidelines.
about
Hyperkalemia among hospitalized patients and association between duration of hyperkalemia and outcomes.Celecoxib and 2,5-dimethylcelecoxib inhibit intestinal cancer growth by suppressing the Wnt/β-catenin signaling pathwayTreatment Considerations for Cancer Pain: A Global Perspective.Comments and Suggestions from Pain Specialists Regarding the CDC's Proposed Opioid Guidelines.2,5-Dimethylcelecoxib prevents pressure-induced left ventricular remodeling through GSK-3 activation.
P2860
Cardiovascular disease and non-steroidal anti-inflammatory drug prescribing in the midst of evolving guidelines.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Cardiovascular disease and non ...... midst of evolving guidelines.
@en
type
label
Cardiovascular disease and non ...... midst of evolving guidelines.
@en
prefLabel
Cardiovascular disease and non ...... midst of evolving guidelines.
@en
P2093
P2860
P356
P1476
Cardiovascular disease and non ...... midst of evolving guidelines.
@en
P2093
Ann E Lloyd
Donald L Harrison
Jeremy L Johnson
Kimberly M Crosby
Michael J Miller
Timothy T Pham
P2860
P304
P356
10.1111/JEP.12014
P577
2012-11-19T00:00:00Z